{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T07:09:27Z","timestamp":1791011367624,"version":"4.1.0"},"publisher-location":"Chichester, UK","reference-count":98,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd002827.pub3","type":"reference-entry","created":{"date-parts":[[2012,5,10]],"date-time":"2012-05-10T20:03:18Z","timestamp":1336680198000},"source":"Crossref","is-referenced-by-count":28,"title":["Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies"],"prefix":"10.1002","author":[{"given":"Michael PT","family":"Lunn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Nobile-Orazio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,5,16]]},"reference":[{"issue":"10","key":"10.1002\/14651858.CD002827.pub3-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1007\/s00415-002-0808-z","article-title":"A randomised controlled trial of intravenous immunoglobulin in IgM paraprotein associated demyelinating neuropathy","volume":"249","author":"Comi","year":"2002","journal-title":"Journal of Neurology"},{"issue":"5","key":"10.1002\/14651858.CD002827.pub3-BIB2|cit2","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/ana.410400516","article-title":"A controlled study of intravenous immunoglobulin in demyelinating neuropathy with IgM gammopathy","volume":"40","author":"Dalakas","year":"1996","journal-title":"Annals of Neurology"},{"issue":"3","key":"10.1002\/14651858.CD002827.pub3-BIB3|cit3","doi-asserted-by":"crossref","first-page":"286-93","DOI":"10.1002\/ana.21577","article-title":"Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein antibody demyelinating neuropathy","volume":"65","author":"Dalakas","year":"2009","journal-title":"Annals of Neurology"},{"issue":"1","key":"10.1002\/14651858.CD002827.pub3-BIB4|cit4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/jnnp.63.1.28","article-title":"A randomised clinical trial comparing interferon-alpha and intravenous immunoglobulin in polyneuropathy associated with monoclonal IgM. The IgM-associated Polyneuropathy Study Group","volume":"63","author":"Mariette","year":"1997","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD002827.pub3-BIB5|cit5","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1136\/jnnp.69.2.279","article-title":"A randomized double blind trial versus placebo does not confirm the benefit of alpha-interferon in polyneuropathy associated with monoclonal IgM","volume":"69","author":"Mariette","year":"2000","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD002827.pub3-BIB6|cit6","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1212\/01.wnl.0000265055.28218.cc","article-title":"Intermittent cyclophosphamide with prednisone versus placebo for polyneuropathy with IgM monoclonal gammopathy","volume":"69","author":"Niermeijer","year":"2007","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD002827.pub3-BIB7|cit7","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1136\/jnnp.59.3.243","article-title":"Plasma exchange and chlorambucil in polyneuropathy associated with monoclonal IgM gammopathy. IgM-associated Polyneuropathy Study Group","volume":"59","author":"Oksenhendler","year":"1995","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD002827.pub3-BIB8|cit8","first-page":"4","article-title":"Rituximab for the treatment of IgM associated polyneuropathies","volume":"10 Suppl 1","author":"Barohn","year":"2005","journal-title":"Journal of the Peripheral Nervous System"},{"issue":"Supplement 1","key":"10.1002\/14651858.CD002827.pub3-BIB9|cit9","first-page":"5","article-title":"Rituximab in anti-MAG polyneuropathy","volume":"10","author":"Benedetti","year":"2005","journal-title":"Journal of the Peripheral Nervous System"},{"issue":"2","key":"10.1002\/14651858.CD002827.pub3-BIB10|cit10","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1529-8027.2007.00129.x","article-title":"Predictors of response to rituximab in patients with neuropathy and anti-myelin associated glycoprotein immunoglobulin M","volume":"12","author":"Benedetti","year":"2007","journal-title":"Journal of the Peripheral Nervous System"},{"issue":"21","key":"10.1002\/14651858.CD002827.pub3-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1212\/01.wnl.0000335268.70325.33","article-title":"Long-term effect of rituximab in anti-MAG polyneuropathy","volume":"71","author":"Benedetti","year":"2008","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD002827.pub3-BIB12|cit12","first-page":"A233","article-title":"Rituximab and IgM autoantibody-associated peripheral neuropathy: The Irish experience","volume":"Suppl 3","author":"Canavan","year":"2002","journal-title":"Neurology"},{"issue":"21","key":"10.1002\/14651858.CD002827.pub3-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1056\/NEJM199111213252105","article-title":"Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance","volume":"325","author":"Dyck","year":"1991","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD002827.pub3-BIB14|cit14","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/mus.20244","article-title":"Rituximab treatment of an IgM monoclonal autonomic and sensory neuropathy","volume":"31","author":"Goldfarb","year":"2005","journal-title":"Muscle & Nerve"},{"issue":"4","key":"10.1002\/14651858.CD002827.pub3-BIB15|cit15","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1212\/01.WNL.0000134676.05850.C0","article-title":"Efficacy of mycophenolate mofetil in patients with chronic immune demyelinating polyneuropathy","volume":"63","author":"Gorson","year":"2004","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD002827.pub3-BIB16|cit16","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/mus.20664","article-title":"Rituximab treatment in patients with IVIg-dependent immune polyneuropathy: a prospective pilot trial","volume":"35","author":"Gorson","year":"2007","journal-title":"Muscle & Nerve"},{"key":"10.1002\/14651858.CD002827.pub3-BIB17|cit17","first-page":"426","article-title":"Intravenous cyclophosphamide in refractory polyneuropathy associated with IgM monoclonal gammopathy: an uncontrolled open trial","volume":"4","author":"Hamidou","year":"118","journal-title":"American Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD002827.pub3-BIB18|cit18","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1080\/14786410500441664","article-title":"Rituximab therapy in monoclonal IgM-related neuropathies","volume":"47","author":"Kilidireas","year":"2006","journal-title":"Leukemia & Lymphoma"},{"key":"10.1002\/14651858.CD002827.pub3-BIB19|cit19","first-page":"A551","article-title":"Therapy of neuropathy associated with anti-MAG IgM monoclonal gammopathy with Rituxan (abstract)","volume":"52 Suppl 2","author":"Latov","year":"1999","journal-title":"Neurology"},{"issue":"9","key":"10.1002\/14651858.CD002827.pub3-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1136\/jnnp.2008.155325","article-title":"Rituximab for polyneuropathy with IgM monoclonal gammopathy","volume":"80","author":"Niermeijer","year":"2009","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD002827.pub3-BIB21|cit21","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1212\/01.wnl.0000247671.58066.21","article-title":"Neurologic and hematologic response to fludarabine treatment in IgM MGUS polyneuropathy","volume":"67","author":"Niermeijer","year":"2006","journal-title":"Neurology"},{"issue":"4","key":"10.1002\/14651858.CD002827.pub3-BIB22|cit22","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1136\/jnnp.74.4.485","article-title":"Treatment of IgM antibody associated polyneuropathies using rituximab","volume":"74","author":"Pestronk","year":"2003","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD002827.pub3-BIB23|cit23","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/mus.10359","article-title":"Rituximab in the treatment of polyneuropathy associated with anti-MAG antibodies","volume":"27","author":"Renaud","year":"2003","journal-title":"Muscle and Nerve"},{"issue":"5","key":"10.1002\/14651858.CD002827.pub3-BIB24|cit24","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1212\/01.wnl.0000201193.00382.b3","article-title":"High-dose rituximab and anti-MAG-associated polyneuropathy","volume":"66","author":"Renaud","year":"2006","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD002827.pub3-BIB25|cit25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s100720070116","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy: long-term course and treatment of 60 patients","volume":"21","author":"Sghirlanzoni","year":"2000","journal-title":"Neurological Sciences"},{"key":"10.1002\/14651858.CD002827.pub3-BIB26|cit26","first-page":"130","article-title":"A phase II trial of rituximab for peripheral neuropathy associated with monoclonal gammopathy of undetermined significance (MGUS)","volume":"16 Suppl s3","author":"Smith","year":"2011","journal-title":"Journal of the Peripheral Nervous System"},{"key":"10.1002\/14651858.CD002827.pub3-BIB27|cit27","first-page":"S19","article-title":"A randomized controlled trial of rituximab in demyelinating neuropathy associated with anti-MAG IgM gammopathy (RIMAG study): study design and progress report","volume":"14 (Suppl s2)","author":"Bombelli","year":"2009","journal-title":"Journal of the Peripheral Nervous System"},{"issue":"5","key":"10.1002\/14651858.CD002827.pub3-BIB28|cit28","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1212\/WNL.41.5.617","article-title":"Research criteria for the diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP)","volume":"41","year":"1991","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD002827.pub3-BIB29|cit29","first-page":"147","article-title":"Autoimmune peripheral neuropathies with anti-MAG antibodies and hematological disorders. Five cases.","volume":"152","author":"Andres","year":"2001","journal-title":"Annales de Medecine Interne"},{"issue":"6","key":"10.1002\/14651858.CD002827.pub3-BIB30|cit30","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1161\/01.STR.20.6.828","article-title":"Interobserver agreement for the assessment of handicap in stroke patients","volume":"20","author":"Bamford","year":"1989","journal-title":"Stroke"},{"issue":"6","key":"10.1002\/14651858.CD002827.pub3-BIB31|cit31","first-page":"1200","article-title":"IgMk monoclonal antibody directed against peripheral nerve myelin; clinical peripheral neuropathy and long-term rheumatic disease","volume":"12","author":"Bland","year":"1985","journal-title":"Journal of Rheumatology"},{"issue":"8","key":"10.1002\/14651858.CD002827.pub3-BIB32|cit32","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1212\/WNL.45.8.1577","article-title":"Anti-MAG antibody-associated polyneuropathies: improvement following immunotherapy with monthly plasma exchange and IV cyclophosphamide","volume":"45","author":"Blume","year":"1995","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD002827.pub3-BIB33|cit33","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/mus.20386","article-title":"Worsening after rituximab treatment in anti-MAG neuropathy","volume":"32","author":"Broglio","year":"2005","journal-title":"Muscle and Nerve"},{"issue":"6","key":"10.1002\/14651858.CD002827.pub3-BIB34|cit34","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/(SICI)1097-4598(199801)21:1<55::AID-MUS8>3.0.CO;2-F","article-title":"Peripheral neuropathy associated with IgM monoclonal gammopathy: correlations between M-protein antibody activity and clinical\/electrophysiological features in 40 cases","volume":"21","author":"Chassande","year":"1998","journal-title":"Muscle and Nerve"},{"key":"10.1002\/14651858.CD002827.pub3-BIB35|cit35","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1212\/WNL.40.2.212","article-title":"High-dose intravenous immunoglobulin in the treatment of demyelinating neuropathy associated with monoclonal gammopathy [see comments]","volume":"40","author":"Cook","year":"1990","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD002827.pub3-BIB36|cit36","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/ana.410100109","article-title":"Polyneuropathy with monoclonal gammopathy: studies of 11 patients","volume":"10","author":"Dalakas","year":"1981","journal-title":"Annals of Neurology"},{"issue":"4","key":"10.1002\/14651858.CD002827.pub3-BIB37|cit37","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s00415-009-5412-z","article-title":"Successful treatment with rituximab of one patient with CANOMAD neuropathy","volume":"257","author":"Delmont","year":"2010","journal-title":"Journal of Neurology"},{"issue":"1","key":"10.1002\/14651858.CD002827.pub3-BIB38|cit38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mus.880120102","article-title":"AAEE case report #17: Peripheral neuropathy in monoclonal gammopathy of undetermined significance","volume":"12","author":"Donofrio","year":"1989","journal-title":"Muscle & Nerve"},{"issue":"10","key":"10.1002\/14651858.CD002827.pub3-BIB39|cit39","first-page":"670","article-title":"Polyneuropathies with IgM monoclonal gammopathy. 12 cases","volume":"143","author":"Dubas","year":"1987","journal-title":"Revue Neurologique"},{"issue":"6","key":"10.1002\/14651858.CD002827.pub3-BIB40|cit40","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/ana.410080608","article-title":"Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry","volume":"8","author":"Dyck","year":"1980","journal-title":"Annals of Neurology"},{"key":"10.1002\/14651858.CD002827.pub3-BIB41|cit41","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/B978-0-7216-9491-7.50043-0","article-title":"Quantitating overall neuropathic symptoms, impairments and outcomes","volume-title":"Peripheral Neuropathy","author":"Dyck","year":"2005"},{"issue":"1","key":"10.1002\/14651858.CD002827.pub3-BIB42|cit42","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/BF00878529","article-title":"Neuropathy associated with 'benign' anti-myelin-associated glycoprotein IgM gammopathy: clinical, immunological, neurophysiological and pathological findings and response to treatment in 33 cases","volume":"243","author":"Ellie","year":"1996","journal-title":"Journal of Neurology"},{"issue":"3","key":"10.1002\/14651858.CD002827.pub3-BIB43|cit43","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0165-5728(86)90001-9","article-title":"Peripheral neuropathy and monoclonal IgM with antibody activity against peripheral nerve myelin; effect of plasma exchange","volume":"11","author":"Ernerudh","year":"1986","journal-title":"Journal of Neuroimmunology"},{"issue":"10","key":"10.1002\/14651858.CD002827.pub3-BIB44|cit44","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1136\/jnnp.55.10.930","article-title":"Immunochemical and clinical effects of immunosuppressive treatment in monoclonal IgM neuropathy","volume":"55","author":"Ernerudh","year":"1992","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD002827.pub3-BIB45|cit45","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s004010050937","article-title":"Antisulfatide polyneuropathy: antibody-mediated complement attack on peripheral myelin","volume":"96","author":"Ferrari","year":"1998","journal-title":"Acta Neuropathologica"},{"key":"10.1002\/14651858.CD002827.pub3-BIB46|cit46","first-page":"195","article-title":"Peripheral neuropathy with gammopathy responding to plasmapheresis","volume":"21","author":"Frayne","year":"1985","journal-title":"Clinical and Experimental Neurology"},{"issue":"8","key":"10.1002\/14651858.CD002827.pub3-BIB47|cit47","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1212\/WNL.59.8.1290","article-title":"Cladribine in the treatment of IgM paraproteinaemic polyneuropathy","volume":"59","author":"Ghosh","year":"2002","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD002827.pub3-BIB48|cit48","first-page":"ECR 17","article-title":"Clinical and immunological worsening in a patient affected with Waldenstrom macroglobulinemia and anti-mag neuropathy after treatment with rituximab","volume":"91 (6 Suppl)","author":"Gironi","year":"2006","journal-title":"Haematologica"},{"issue":"6","key":"10.1002\/14651858.CD002827.pub3-BIB49|cit49","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jocn.2005.09.008","article-title":"Rituximab therapy in chronic inflammatory demyelinating polyradiculoneuropathy with anti-SGPG IgM antibody","volume":"13","author":"Gono","year":"2006","journal-title":"Journal of Clinical Neuroscience"},{"issue":"2","key":"10.1002\/14651858.CD002827.pub3-BIB50|cit50","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1212\/WNL.48.2.321","article-title":"Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy","volume":"48","author":"Gorson","year":"1997","journal-title":"Neurology"},{"issue":"6","key":"10.1002\/14651858.CD002827.pub3-BIB51|cit51","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/mus.1069","article-title":"Treatment experience in patients with anti-myelin-associated glycoprotein neuropathy","volume":"24","author":"Gorson","year":"2001","journal-title":"Muscle & Nerve"},{"issue":"3","key":"10.1002\/14651858.CD002827.pub3-BIB52|cit52","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1529-8027.2011.00343.x","article-title":"Long-term response to rituximab and fludarabine combination in IgM anti-myelin-associated glycoprotein neuropathy","volume":"16","author":"Gruson","year":"2011","journal-title":"Journal of the Peripheral Nervous System"},{"issue":"4","key":"10.1002\/14651858.CD002827.pub3-BIB53|cit53","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/ana.410230415","article-title":"Plasmapheresis alleviates neuropathy accompanying IgM anti-myelin-associated glycoprotein paraproteinemia","volume":"23","author":"Haas","year":"1988","journal-title":"Annals of Neurology"},{"issue":"1","key":"10.1002\/14651858.CD002827.pub3-BIB54|cit54","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1212\/WNL.36.1.75","article-title":"Monoclonal gammopathy and neuropathy; myelin associated glycoprotein reactivity and clinical characteristics","volume":"36","author":"Hafler","year":"1986","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD002827.pub3-BIB55|cit55","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0165-5728(88)90101-4","article-title":"Immune reactive C3d on the surface of myelin sheaths in neuropathy","volume":"18","author":"Hays","year":"1988","journal-title":"Journal of Neuroimmunology"},{"key":"10.1002\/14651858.CD002827.pub3-BIB56|cit56","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"6-7","key":"10.1002\/14651858.CD002827.pub3-BIB57|cit57","first-page":"385","article-title":"Treatment of immune deficient neuropathies with intravenous polyvalent immunoglobulins. An open study of 16 cases","volume":"149","author":"Hoang-Xuan","year":"1993","journal-title":"Revue Neurologique"},{"issue":"4","key":"10.1002\/14651858.CD002827.pub3-BIB58|cit58","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/jnnp.53.4.327","article-title":"Cyclosporin A in the treatment of chronic demyelinating polyradiculoneuropathy","volume":"53","author":"Hodgkinson","year":"1990","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"1-2","key":"10.1002\/14651858.CD002827.pub3-BIB59|cit59","first-page":"87","article-title":"Induction of experimental ataxic sensory neuronopathy in cats by immunization with purified SGPG","volume":"193","author":"Ilyas","year":"2008","journal-title":"Journal of the Peripheral Nervous System"},{"issue":"Pt 5","key":"10.1002\/14651858.CD002827.pub3-BIB60|cit60","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1093\/brain\/117.5.941","article-title":"Distal accentuation of conduction slowing in polyneuropathy associated with antibodies to myelin-associated glycoprotein and sulphated glucoronyl paragloboside","volume":"117","author":"Kaku","year":"1994","journal-title":"Brain"},{"issue":"11","key":"10.1002\/14651858.CD002827.pub3-BIB61|cit61","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1212\/WNL.31.11.1480","article-title":"Prevalence of monoclonal protein in peripheral neuropathy","volume":"31","author":"Kelly","year":"1981","journal-title":"Neurology"},{"issue":"12","key":"10.1002\/14651858.CD002827.pub3-BIB62|cit62","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1001\/archneur.1988.00520360073015","article-title":"Polyneuropathies associated with IgM monoclonal gammopathies","volume":"45","author":"Kelly","year":"1988","journal-title":"Archives of Neurology"},{"issue":"2","key":"10.1002\/14651858.CD002827.pub3-BIB63|cit63","first-page":"78","article-title":"Chronic peripheral neuropathy responsive to rituximab","volume":"3","author":"Kelly","year":"2006","journal-title":"Reviews in Neurological Diseases"},{"issue":"11","key":"10.1002\/14651858.CD002827.pub3-BIB64|cit64","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1056\/NEJM198009113031105","article-title":"Plasma cell dyscrasia and peripheral neuropathy with a monoclonal antibody to peripheral nerve myelin","volume":"303","author":"Latov","year":"1980","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD002827.pub3-BIB65|cit65","first-page":"301","article-title":"Peripheral neuropathy and anti-MAG antibodies","volume":"3","author":"Latov","year":"1988","journal-title":"Critical Reviews in Neurobiology"},{"issue":"8","key":"10.1002\/14651858.CD002827.pub3-BIB66|cit66","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1212\/WNL.52.8.1701","article-title":"IgM antibody-related polyneuropathies: B-cell depletion chemotherapy using rituximab","volume":"52","author":"Levine","year":"1999","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD002827.pub3-BIB67|cit67","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1136\/jnnp.57.Suppl.46","article-title":"Human immunoglobulin treatment of multifocal motor neuropathy and polyneuropathy associated with monoclonal gammopathy","volume":"57 Suppl","author":"L\u00e9ger","year":"1994","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD002827.pub3-BIB68|cit68","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF00690395","article-title":"Polyneuropathy in Waldenstrom's macroglobulinaemia: reduction of endoneurial IgM-deposits after treatment with chlorambucil and plasmapheresis","volume":"64","author":"Meier","year":"1984","journal-title":"Acta Neuropathologica"},{"issue":"11","key":"10.1002\/14651858.CD002827.pub3-BIB69|cit69","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1212\/WNL.33.11.1397","article-title":"Peripheral neuropathy with IgM kappa monoclonal immunoglobulin directed against myelin-associated glycoprotein","volume":"33","author":"Melmed","year":"1983","journal-title":"Neurology"},{"issue":"8","key":"10.1002\/14651858.CD002827.pub3-BIB70|cit70","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1212\/WNL.53.8.1648","article-title":"Fatigue in immune-mediated polyneuropathies. European Inflammatory Neuropathy Cause and Treatment (INCAT) Group","volume":"53","author":"Merkies","year":"1999","journal-title":"Neurology"},{"issue":"4","key":"10.1002\/14651858.CD002827.pub3-BIB71|cit71","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1212\/WNL.54.4.943","article-title":"Psychometric evaluation of a new sensory scale in immune-mediated polyneuropathies. Inflammatory Neuropathy Cause and Treatment (INCAT) Group","volume":"54","author":"Merkies","year":"2000","journal-title":"Neurology"},{"issue":"10","key":"10.1002\/14651858.CD002827.pub3-BIB72|cit72","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1056\/NEJM199003083221002","article-title":"Complement-mediated demyelination in patients with IgM monoclonal gammopathy and polyneuropathy","volume":"322","author":"Monaco","year":"1990","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD002827.pub3-BIB73|cit73","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/mus.1214","article-title":"Proposed revised electrophysiological criteria for chronic inflammatory demyelinating polyradiculoneuropathy","volume":"25","author":"Nicolas","year":"2002","journal-title":"Muscle & Nerve"},{"key":"10.1002\/14651858.CD002827.pub3-BIB74|cit74","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/(SICI)1098-1101(1999)14:4<159::AID-JCA1>3.0.CO;2-Q","article-title":"Response of patients with IgM and IgA-associated peripheral polyneuropathies to \"off-line\" immunoadsorption treatment using the Prosorba Protein A column","volume":"14","author":"Niemierko","year":"1999","journal-title":"Journal of Clinical Apheresis"},{"issue":"1","key":"10.1002\/14651858.CD002827.pub3-BIB75|cit75","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/ana.410240118","article-title":"Treatment of patients with neuropathy and anti-MAG IgM M-proteins","volume":"24","author":"Nobile-Orazio","year":"1988","journal-title":"Annals of Neurology"},{"issue":"Pt 4","key":"10.1002\/14651858.CD002827.pub3-BIB76|cit76","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/brain\/123.4.710","article-title":"Long-term prognosis of neuropathy associated with anti-MAG IgM M-proteins and its relationship to immune therapies","volume":"123","author":"Nobile-Orazio","year":"2000","journal-title":"Brain"},{"issue":"1","key":"10.1002\/14651858.CD002827.pub3-BIB77|cit77","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1200\/JCO.2005.04.6474","article-title":"Flare in neuropathy following rituximab therapy for Waldenstrom\u2019s macroglobulinemia","volume":"24","author":"Noronha","year":"2006","journal-title":"Journal of Clinical Oncology"},{"issue":"5","key":"10.1002\/14651858.CD002827.pub3-BIB78|cit78","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1212\/WNL.47.5.1227","article-title":"Intermittent cyclophosphamide and prednisone treatment of polyneuropathy associated with monoclonal gammopathy of undetermined significance","volume":"47","author":"Notermans","year":"1996","journal-title":"Neurology"},{"issue":"7","key":"10.1002\/14651858.CD002827.pub3-BIB79|cit79","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s004150050124","article-title":"Pulsed high-dose dexamethasone treatment of polyneuropathy associated with monoclonal gammopathy","volume":"244","author":"Notermans","year":"1997","journal-title":"Journal of Neurology"},{"key":"10.1002\/14651858.CD002827.pub3-BIB80|cit80","first-page":"A47","article-title":"Improvement of sensory ataxia in anti-MAG antibody associated polyneuropathy with interferon alpha: A posturographic study","volume":"54 Suppl 3","author":"Pouget","year":"2000","journal-title":"Neurology"},{"issue":"12","key":"10.1002\/14651858.CD002827.pub3-BIB81|cit81","doi-asserted-by":"crossref","first-page":"1814-6","DOI":"10.1212\/01.WNL.0000098996.02934.86","article-title":"Chronic neuropathy with IgM antiganglioside antibodies: lack of long term response to rituximab","volume":"61","author":"Rojas-Garc\u00eda","year":"2003","journal-title":"Neurology"},{"issue":"4","key":"10.1002\/14651858.CD002827.pub3-BIB82|cit82","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1212\/WNL.51.4.1210","article-title":"Nervous system dysfunction in Waldenstrom's macroglobulinemia: response to treatment","volume":"51","author":"Rudnicki","year":"1998","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD002827.pub3-BIB83|cit83","volume-title":"Cross-over trials in clinical research","author":"Senn","year":"1993"},{"issue":"8","key":"10.1002\/14651858.CD002827.pub3-BIB84|cit84","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1136\/jnnp.47.8.813","article-title":"Plasma exchange treatment of peripheral neuropathy associated with plasma cell dyscrasia","volume":"47","author":"Sherman","year":"1984","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD002827.pub3-BIB85|cit85","first-page":"326","article-title":"Fludarabine for IgM antibody-mediated neuropathies","volume":"36","author":"Sherman","year":"1994","journal-title":"Annals of Neurology"},{"issue":"2","key":"10.1002\/14651858.CD002827.pub3-BIB86|cit86","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1600-0404.1994.tb01646.x","article-title":"Selective techniques of apheresis in polyneuropathy associated with monoclonal gammopathy of undetermined significance","volume":"89","author":"Siciliano","year":"1994","journal-title":"Acta Neurologica Scandanavica"},{"issue":"Pt 1","key":"10.1002\/14651858.CD002827.pub3-BIB87|cit87","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/brain\/106.1.169","article-title":"Chronic demyelinating neuropathy associated with benign IgM paraproteinaemia","volume":"106","author":"Smith","year":"1983","journal-title":"Brain"},{"issue":"4","key":"10.1002\/14651858.CD002827.pub3-BIB88|cit88","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1600-0404.1987.tb07927.x","article-title":"Peripheral Neuropathy associated with plasma cell dyscrasia: a clinical and electrophysiological follow-up study","volume":"75","author":"Smith","year":"1987","journal-title":"Acta Neurologica Scandanavica"},{"key":"10.1002\/14651858.CD002827.pub3-BIB89|cit89","first-page":"400","article-title":"Anti-glycoconjugate antibodies and dysglobulinemic or dysimmune peripheral neuropathies","volume":"152","author":"Steck","year":"1996","journal-title":"Revue Neurologique"},{"issue":"4","key":"10.1002\/14651858.CD002827.pub3-BIB90|cit90","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF00691490","article-title":"Neuropathy accompanying IgM lambda monoclonal gammopathy","volume":"59","author":"Stefansson","year":"1983","journal-title":"Acta Neuropathologica"},{"issue":"5","key":"10.1002\/14651858.CD002827.pub3-BIB91|cit91","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/mus.1059","article-title":"Parameters for monitoring treatment effects in CIDP with anti-MAG\/SGPG IgM antibody","volume":"24","author":"Tagawa","year":"2001","journal-title":"Muscle & Nerve"},{"issue":"2","key":"10.1002\/14651858.CD002827.pub3-BIB92|cit92","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/ana.410180203","article-title":"Immunofluorescence study of patients with neuropathy and IgM M proteins","volume":"18","author":"Takatsu","year":"1985","journal-title":"Annals of Neurology"},{"issue":"5","key":"10.1002\/14651858.CD002827.pub3-BIB93|cit93","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/ana.410330514","article-title":"Experimental paraprotein neuropathy, demyelination by passive transfer of human IgM anti-myelin-associated glycoprotein","volume":"33","author":"Tatum","year":"1993","journal-title":"Annals of Neurology"},{"issue":"4","key":"10.1002\/14651858.CD002827.pub3-BIB94|cit94","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1046\/j.1365-2141.2000.02086.x","article-title":"The polyneuropathy associated with Waldenstr\u00f6m's macroglobulinaemia can be treated effectively with chemotherapy and the anti-CD20 monoclonal antibody rituximab","volume":"109","author":"Weide","year":"2000","journal-title":"British Journal of Haematology"},{"issue":"11","key":"10.1002\/14651858.CD002827.pub3-BIB95|cit95","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/mus.880111111","article-title":"Demyelination induced by intraneural injection of human antimyelin-associated glycoprotein antibodies","volume":"11","author":"Willison","year":"1988","journal-title":"Muscle and Nerve"},{"issue":"10","key":"10.1002\/14651858.CD002827.pub3-BIB96|cit96","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1093\/brain\/124.10.1968","article-title":"The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies","volume":"124","author":"Willison","year":"2001","journal-title":"Brain"},{"issue":"5","key":"10.1002\/14651858.CD002827.pub3-BIB97|cit97","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/jnnp.66.5.575","article-title":"Successful treatment of IgM paraproteinaemic neuropathy with fludarabine","volume":"66","author":"Wilson","year":"1999","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD002827.pub3-BIB98|cit98","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/BF00319857","article-title":"The clinical spectrum of peripheral neuropathies associated with benign monoclonal IgM, IgG and IgA paraproteinaemia. Comparative clinical, immunological and nerve biopsy findings","volume":"238","author":"Yeung","year":"1991","journal-title":"Journal of Neurology"}],"updated-by":[{"DOI":"10.1002\/14651858.cd002827.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,10,4]],"date-time":"2016-10-04T00:00:00Z","timestamp":1475539200000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD002827.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T21:12:57Z","timestamp":1628543577000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD002827.pub3"}},"subtitle":[],"editor":[{"given":"Michael PT","family":"Lunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,5,16]]},"references-count":98,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd002827.pub3","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD002827.pub4","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2012,5,16]]}}}